Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

smoking

Diabetes drug may help people quit smoking

May 1, 2019
Research and Development UTHealth, clinical trials, diabetes, smoking smoking cessation

A diabetes drug may help people quit smoking, according to researchers at the University of Texas Health Science Center at …

News
shutterstock_243110086

Sanofi and Lexicon’s Zynquista scores EU approval for type 1 diabetes patients

April 29, 2019
Sales and Marketing Lexicon, Sanofi, Type 1 diabetes, Zynquista, diabetes, pharma

The European Commission has authorised the use of Sanofi and Lexicon’s Zynquista (sotagliflozin) in Europe in the treatment of specific …

News
janssen_latest_logo_on_sign

Janssen’s Invokana combo smashes primary and secondary endpoints in chronic kidney disease

April 16, 2019
Manufacturing and Production, Research and Development Janssen, cardiovascular, chronic kidney disease, diabetes, invokana, pharma

Janssen has unveiled promising new Phase 3 for its sodium-glucose transport (SGLT) protein-2 inhibitor Invokana (canagliflozin), showing that the therapy …

News
novo_nordisk_flag

Novo Nordisk’s oral semaglutide outclasses Januvia with new data in type 2 diabetes

March 26, 2019
Manufacturing and Production, Research and Development Novo Nordisk, Ozempic, diabetes, pharma, type 2 diabetes

Novo Nordisk has revealed new dose-specific Phase 3a data for its glucagon-like peptide-1 (GLP-1) analogue oral semaglutide, indicating that the …

News
fda2outsideweb

Sanofi and Lexicon’s Zynquista denied type 1 diabetes approval by FDA complete response letter

March 25, 2019
Sales and Marketing Zynquista. FDA, diabetes, pharma

Sanofi and Lexicon’s Zynquista (sotagliflozin) has hit a hurdle on its way to US approval for the treatment of type …

News
astrazeneca_building_white

AZ’s diabetes drug Forxiga secures EU approval for adjunctive use in type 1 patients

March 25, 2019
Sales and Marketing AstraZeneca, Forxiga, diabetes, pharma

AstraZeneca has revealed that its sodium-glucose co-transporter 2 (SGLT2) inhibitor Forxiga (dapagliflozin) has secured approval from the European Commission for …

News

23andMe to offer genetic reports on diabetes

March 11, 2019
Sales and Marketing 23andME, Genentech, GlaxoSmithKline, Lundbeck, diabetes, genetics, genomics

Personal genomics company, 23andMe will offer customers information on the likelihood that they are genetically predisposed to developing type 2 …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 22, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease

Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …

News
5204602349_c87b204860_z

FDA to crack down on dietary supplements

February 12, 2019
Manufacturing and Production Alzheimer's, Alzheimers, Cancer, Dietary Supplements, FDA, USA, diabetes

The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, …

News

Insider Interview: The diabetes/mental health connection

December 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Type 1 diabetes, World Diabetes Day, diabetes, feature, mental health, pharma

Michael Connellan, Head of External Affairs at the type 1 diabetes charity JDRF, discusses the results of a recent survey …

Feature
novo_nordisk_flag

Novo Nordisk’s semaglutide meets primary endpoint of reducing cardiovascular events at Phase 3

November 26, 2018
Research and Development, Sales and Marketing Novo Nordisk, diabetes, pharma, semaglutide

Novo Nordisk has revealed new Phase 3a data for its investigational GLP-1 analogue therapy semaglutide, showing that the drug met …

News
diabetes-777001_960_720

3 in 4 UK diabetes patients suffer from mental health issues, says report

November 14, 2018
Medical Communications, Research and Development UK, World Diabetes Day, diabetes, pharma

To mark this year’s World Diabetes Day on 14 November, a new report has shed more light on the psychological …

News

NHS diabetes prescriptions top £1 billion a year

November 9, 2018
Medical Communications, Sales and Marketing Health Education England, NHS, UK, diabetes, pharma

The NHS in England is now spending over £1billion a year on diabetes prescriptions, almost doubling in the last decade, …

News

Galectin-3: The protein paving new treatment avenues

November 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma

Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …

Feature
eye2

Common diabetes drug can protect against age-related macular degeneration, research shows

October 31, 2018
Research and Development age-related macular degeneration, diabetes, eye, metformin, pharma

A Taiwanese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026